Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer

Clinical trial NCT00225784 · COMPLETED

Trial details

NCT number: NCT00225784
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2005-02-01
Primary completion: 2010-02-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.